CB3: 10-PROPARGYL-5,8-DIDEAZAFOLIC ACID
CB3 is a Ligand Of Interest in 4ECK designated by the RCSB
| Best-fitted instance in this entry |
| Other instances in this entry |
| Best-fitted instance in this entry |
| Best-fitted PDB instances with different target (top 5) |
| Identifier | Ranking for goodness of fit | Ranking for geometry | Real space R factor | Real space correlation coefficient | RMSZ-bond-length | RMSZ-bond-angle | Outliers of bond length | Outliers of bond angle | Atomic clashes | Stereochemical errors | Model completeness | Average occupancy |
|---|
| 4ECK_CB3_A_702 | 2% | 16% | 0.476 | 0.738 | 1.27 | 2.54 | 3 | 12 | 14 | 0 | 100% | 1 |
| 4ECK_CB3_B_702 | 1% | 18% | 0.526 | 0.738 | 1.28 | 2.4 | 3 | 11 | 18 | 0 | 100% | 1 |
| 6NNR_CB3_B_302 | 93% | 21% | 0.076 | 0.97 | 1.19 | 2.25 | 3 | 8 | 0 | 0 | 100% | 1 |
| 4GEV_CB3_B_802 | 87% | 21% | 0.081 | 0.954 | 1.23 | 2.21 | 3 | 8 | 0 | 0 | 100% | 1 |
| 2FTO_CB3_X_266 | 82% | 19% | 0.087 | 0.943 | 1.58 | 2 | 6 | 6 | 1 | 0 | 100% | 1 |
| 4EIL_CB3_G_702 | 76% | 11% | 0.105 | 0.941 | 1.96 | 2.43 | 8 | 13 | 1 | 0 | 100% | 1 |
| 6CDZ_CB3_A_701 | 53% | 22% | 0.16 | 0.922 | 1.31 | 2.06 | 3 | 11 | 0 | 0 | 100% | 1 |
